Solesence Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $55.4M+5.8% YoYTTM through 30 Jun 2026
Net Income -$2.9M-168.6% YoYTTM through 30 Jun 2026
Free Cash Flow -$3.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 26.0% |
| EBITDA Margin | -1.7% |
| Operating Margin | 1.3% |
| Net Margin | -5.3% |
Returns
5.6%ROE
2.0%ROA
Balance Sheet Health
Debt / Equity0.80x
Current Ratio2.07x
Net Debt$12.9M
Cash & Equivalents$1M
Quality Metrics
Altman Z-Score-1.06
Piotroski F-Score3 / 9
FCF Margin-6.4%
Multi-Year Trend
RevenueFY2025: $62.1M
Diluted EPS-$0.05TTMFY2025: $0.02
Dividend
No dividend
Capital Allocation
R&D Spend$4.1M
Capex Intensity8.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Consumer Products | $44.4M | +76.2% | View detailsRemains the primary growth driver for the company as it scales its SPF-infused beauty products. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.